ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
1.740
-0.070 (-3.87%)
At close: Sep 15, 2026, 4:00 PM EDT
1.750
+0.010 (0.57%)
After-hours: Sep 15, 2026, 7:53 PM EDT
ProKidney Revenue
ProKidney had revenue of $150.00K in the quarter ending June 30, 2026, a decrease of -32.13%. This brings the company's revenue in the last twelve months to $818.00K, up 55.22% year-over-year. In the year 2025, ProKidney had annual revenue of $893.00K with 1,075.00% growth.
Revenue (ttm)
$818.00K
Revenue Growth
+55.22%
P/S Ratio
643.08
Revenue / Employee
$3,541
Employees
231
Market Cap
526.04M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 893.00K | 817.00K | 1,075.00% |
| Dec 31, 2024 | 76.00K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Arvinas | 316.70M |
| REGENXBIO | 174.48M |
| Autolus Therapeutics | 117.39M |
| OmniAb | 38.46M |
| Scribe Therapeutics | 33.30M |
| Opus Genetics | 9.86M |
| Prime Medicine | 4.07M |
| Ovid Therapeutics | 1.58M |
PROK News
- 19 days ago - 20 stocks likely to lose money even if the bull market continues - Market Watch
- 5 weeks ago - ProKidney reports Q2 EPS (15c), consensus (14c) - TheFly
- 5 weeks ago - ProKidney Quarterly report: Q2 2026 - Filings
- 5 weeks ago - ProKidney Earnings release: Q2 2026 - Filings
- 3 months ago - ProKidney Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 3 months ago - ProKidney appoints Kenneth Locke as chief technical officer - TheFly
- 3 months ago - ProKidney Appoints Kenneth Locke as Chief Technical Officer - GlobeNewsWire
- 3 months ago - ProKidney Transcript: AGM 2026 - Transcripts